Title

Expert Review of Clinical Pharmacology

2023
- October
  - Volume 16
    - Issue 10
- September
  - Volume 16
    - Issue 9
- August
  - Volume 16
    - Issue 8
- July
  - Volume 16
    - Issue 7
- June
  - Volume 16
    - Issue 6
- May
  - Volume 16
    - Issue 5
- April
  - Volume 16
    - Issue 4
- March
  - Volume 16
    - Issue 3
- February
  - Volume 16
    - Issue 2
- January
  - Volume 16
    - Issue 1
2022
- December
  - Volume 15
    - Issue 12
- November
  - Volume 15
    - Issue 11
- October
  - Volume 15
    - Issue 10
- September
  - Volume 15
    - Issue 9
- August
  - Volume 15
    - Issue 8
- July
  - Volume 15
    - Issue 7
- June
  - Volume 15
    - Issue 6
- May
  - Volume 15
    - Issue 5
- April
  - Volume 15
    - Issue 4
- March
  - Volume 15
    - Issue 3
    - Issue 1
- February
  - Volume 15
    - Issue 2

Medilib Journal is a reliable source of researches and researches in the field of medicine. The philosophy of journals is to preserve scientific materials and register them in the name of the author and prevent plagiarism.

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and âindividualizedâ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.